Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Phillip J MeaseRichard B WarrenPeter NashJean-Marie GrouinNikos LyrisDamon WillemsVanessa TaiebJason EellsIain B McInnesPublished in: Rheumatology and therapy (2024)
NCT03895203, NCT03896581, NCT03675308, NCT03671148.
Keyphrases